The GMP Drug Substance process begins with cell banking. Master Cell Bank (MCB) and Working Cell Bank (WCB) manufacturing must be worked out according to Live Biotherapeutic Product Guidelines, and Biose Industrie is fully equipped to do so. Where does Biose Industrie house the cell banking equipment? Biose Industrie has..Read more
GMP Drug Substance Development is an important part of product development for clients of Biose Industrie. Our team members are expert problem solvers who ensure the manufacturing consistently outputs a live biotherapeutic product to certain quality specifications, while documenting all steps in the process. Several stages are involved: Selecting a..Read more
The first step in process development for live biotherapeutic product manufacturing is to identify the microbe that will be used in the drug product and assess the conditions it needs to grow. There are several parameters that must be taken into account, as different bacteria will require different approaches. Aerobic..Read more
Established since 1951, we provide a full range of services as a CDMO for Live Biotherapeutic Products (LPBs).
